Printer Friendly

MediPurpose Supports Diabetes Research Effort.

MediPurpose (Norcross, GA), the manufacturer of the SurgiLance safety lancet, has made a donation of $1,000 to the Juvenile Diabetes Research Foundation (JDRF) to support ongoing research efforts. MediPurpose made the recent gift in celebration of the sale of its 500 millionth safety lancet to St. Louis-based distributor MMS Medical.

"MediPurpose is dedicated to improving the quality of life for those living with diabetes. Our SurgiLance safety lancets are used by them for regular glucose testing," says MediPurpose CEO Patrick Yi.

JDRF is the world's largest charitable funder of and advocate for type 1 (juvenile) diabetes research worldwide. Type 1 Diabetes is a disease which strikes children suddenly and requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Since its inception in 1970, JDRF has raised more than $1.9 billion to fund direct research.

"With the generous support of companies such as MediPurpose, JDRF can continue its mission to discover, develop and deliver therapeutics to improve the lives of people with diabetes," said Marie Davis, executive director of the organization's Metro Saint Louis / Greater Missouri Chapter.

MediPurpose develops, manufactures and markets innovative healthcare solutions valued by its customers. The company is known for introducing quality safety medical devices that protect healthcare professionals from sharps injury. Founded in 1999, the company achieved rapid success with its SurgiLance safety lancet, quickly becoming one of the top leaders in the US safety lancet market and establishing solid distribution channels worldwide.

The SurgiLance safety lancet has found long-term success in all sectors of the healthcare market and has provided more than 500 million consumers with a safe, simple and effective tool for blood testing. MediPurpose currently offers six color-coded lancets, which are used for capillary blood sampling for a range of testing requirements.

MediPurpose maintains offices in the US, Singapore, the UK, France and Spain. As a globally recognized innovator, MediPurpose has developed a menu of services to assist inventors and growing medical device companies successfully design, patent, manufacture and sell their products.

MediPurpose

+1-770-448-9493

www.medipurpose.com
COPYRIGHT 2008 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Mar 1, 2008
Words:342
Previous Article:Gen-Probe Begins United States Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer.
Next Article:Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program.
Topics:


Related Articles
Diabetes nurses win research funding.
Foundation Seeks $11 Million to Fund Promising Research in Humans; Diabetes in Mice Cured Using Non-Embryonic Sources.
Developing a new diabetes education model.
NIH releases long range plan to guide research in type 1 diabete; increased islet cell transplants a major goal.
Riding to fund diabetes study; A father cycles to aid research.
How camps can help adolescents self-manage diabetes: research.
Manpei Suzuki Diabetes Foundation Announces New International Prize for Diabetes Research.
Oral health and diabetes educational efforts.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters